New Antibiotic Drug Developed by HKU Chemistry Research Team Approved for Clinical Trials in Humans
⾹港⼤學理學院化學系李學臣教授的研究團隊歷時⼗年研發的抗⽣素新藥 ——咔喏霉素 （Kynomycin），剛獲得國家藥品監督管理局核准簽發《藥物臨床試驗批准通知書》，同意開展作臨床試驗。咔喏霉素是具有全新化學結構的環脂肽類 1 類化學新藥，主要針對細菌導致的複雜性⽪膚及軟組 織感染。
HKU Scientists Pioneer Dual Trojan Horse Approach to Combat Superbugs
港⼤團隊開發雙重特洛伊⽊⾺⾦屬-鐵霉素複合物 為對抗细菌耐藥性提供新思路
Chemists developed a highly active and selective catalytic material that can efficiently convert a potent greenhouse into an essential chemical.
香港大學(港大)化學系郭正曉教授、清華大學化學工程系唐軍旺教授與倫敦大學學院研究人員共同開發了一種高活性和高選擇性的催化材料。
HKU scientists have discovered that bacteria in Tolo Harbour are antibiotic-resistant, meaning infection by such bacteria may be potentially fatal.
Re-sensitise the last-line Antimicrobial Colistin against superbugs
古藥新⽤：⼆千年歷史抗菌藥硝酸銀 與「最後防線抗⽣素」粘菌素組合 可對抗耐藥性超級細菌e-sensitise the last-line Antimicrobial Colistin against superbugs
